Connor, Clark & Lunn Investment Management Ltd. Brainstorm Cell Therapeutics Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$18.8 Billion
Q3 2024

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2023 Aug 10, 2023	BUY	$2.0 - $3.2 $23,722 - $37,955	11,861 New	11,861 $24,000

Others Institutions Holding BCLI

# of Institutions

Shares Held

10.8M

Call Options Held

160K

Put Options Held

30.5K

Armistice Capital, LLC New York, NY

6.9M
Shares

$15.7 Million
0.03% of portfolio
Vanguard Group Inc Valley Forge, PA

1.51M
Shares

$3.44 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

683K
Shares

$1.56 Million
0.0% of portfolio
Black Rock Inc. New York, NY

386K
Shares

$881,023
0.0% of portfolio
Liberty Wealth Management LLC Oakland, CA

340K
Shares

$775,541
0.01% of portfolio

View Full List

About BRAINSTORM CELL THERAPEUTICS INC.

Ticker BCLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,486,200
Market Cap $83.2M
Description
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...

More about BCLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account